Moderna receives $176 million from the U.S. government to accelerate bird flu vaccine development, using mRNA technology similar to COVID-19 vaccines.
Funding includes late-stage trials next year, with the ability to pivot to different influenza strains if needed, funded by BARDA.
[
Collection
]
[
|
...
]